Target intelligence / Profile preview

Chromosome 9 open reading frame 72 protein (C9orf72)

Target
C9orf72
Molecular classification
Other (DENN domain–containing protein family; not a classic receptor, enzyme, or transporter but involved in vesicle trafficking and autophagy regulation), Protein complex subunit
01

Overview

Chromosome 9 open reading frame 72 protein (*C9orf72*) is encoded by the *C9orf72* gene located at cytogenetic band 9p21.2 on human chromosome 9. The protein plays an important role in regulating endosomal trafficking, lysosome homeostasis, autophagy, and nutrient-dependent mTORC1 signaling through interactions with SMCR8 and WDR41 proteins—forming a functional complex critical for neuronal health. Pathogenic hexanucleotide GGGGCC repeat expansions within an intronic region cause both familial amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), making it one of the most common genetic causes identified for these neurodegenerative disorders. Disease mechanisms involve both gain-of-function toxicity from abnormal RNA/protein products generated from expanded repeats as well as loss-of-function effects due to reduced levels or dysfunction of normal C9ORF72 protein.

Other names
C9orf72C9ORF72-SMCR8 complex subunitALSFTDFTDALSchromosome Z C9orf72 homolog (CZH9orf72)RIKEN cDNA 3110043O21 gene (3110043O21Rik)similar to RIKEN cDNA 3110043O21 (RGD1359108)chromosome 9 open reading frame 72 L homeolog (c9orf72.L)
02

Mechanism of action

Experimental therapeutics aim to reduce toxic RNA foci or dipeptide repeat proteins produced by pathogenic hexanucleotide repeat expansions within the *C9orf72* gene. Approaches include antisense oligonucleotides that bind mutant RNA transcripts for degradation or prevent their translation into toxic peptides; other strategies may involve modulating autophagy pathways affected by loss-of-function mutations in C9orf72.

03

Biological functions

Regulation of endosomal traffickingAutophagy regulationLysosome homeostasismTORC1 signaling modulationVesicle trafficking and cellular waste degradation
04

Disease associations

Neurodegenerative disease (specifically ALS and FTD)There is also emerging evidence for possible roles in cancer due to its involvement with mTORC1 signaling pathways, though this is less established at present
05

Safety considerations

Therapeutic challenges include ensuring specificity when targeting mutant versus wild-type alleles since complete loss-of-function could disrupt normal cellular processes such as autophagy and lysosomal function.Off-target effects on related DENN domain–containing proteins must also be considered due to shared structural features with other essential cellular regulators.
06

Interacting drugs

No approved drugs directly targeting the C9orf72 protein are currently available. However, research into modulators of its expression or function is ongoing for potential therapies targeting ALS/FTD caused by repeat expansions in the gene. Experimental approaches include antisense oligonucleotides and small molecules that modulate transcription or translation of mutant alleles.
07

Biomarkers

The presence of expanded GGGGCC repeats (>30 copies) within intronic regions of *C9orf72* serves as a genetic biomarker for familial forms of ALS/FTD. Detection can be performed via genetic testing when these diseases are suspected clinically.Accumulation of dipeptide repeat proteins derived from non-canonical translation events may also serve as pathological biomarkers in affected tissues

Beyond the preview

Go deeper on Chromosome 9 open reading frame 72 protein (C9orf72).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chromosome 9 open reading frame 72 protein (C9orf72).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call